Immunogenicity and safety of a booster COVID‐19 vaccination in patients with chronic liver disease: A multicenter study

Jitao Wang(Hebei Medical University), Wenhong Zhang(Fudan University), Faren Xie(Nanjing University of Chinese Medicine), Jingwen Ai(Fudan University), Xiaolin Lan(Lishui City People's Hospital), Qiran Zhang(Fudan University), Shubo Chen(Hebei Medical University), Shujun Jiang(Nanjing University of Chinese Medicine), Zhiyun Hou(Zoucheng People's Hospital), Nina Zhang(Nanjing Drum Tower Hospital), Wenchuan Wang(North China University of Water Resources and Electric Power), Yanliang Zhang(University of Notre Dame), Dengxiang Liu(Hebei Medical University), Wei Rao(Qingdao University), Huiling Xiang(Tianjin Third Central Hospital), Xuying Zhang(Hebei Medical University), Chuan Liu(Wuhan University), Qun Zhang(Second Affiliated Hospital of Jilin University), Qiuju Tian(Qingdao University), Jing Liang(Jiaxing Vocational Technical College), Qianqian Li(Tianjin Third Central Hospital), Aiguo Zhang(Henan University), Jiaojian Lv(Lishui City People's Hospital), Jinlong Li(Hebei Medical University), Xiaolong Qi(Zhongda Hospital Southeast University)
Portal hypertension & cirrhosis
September 1, 2023
Cited by 0


Related Papers